Smart Wearable Glucose Patch Global Market Report 2025

The smart wearable glucose patch market size has grown rapidly in recent years. It will grow from $1.87 billion in 2024 to $2.22 billion in 2025 at a compound annual growth rate (CAGR) of 18.4%. The growth during the historic period can be attributed to the rising awareness of health and fitness, the growing adoption of wireless connectivity and smartphone applications, the increasing support from healthcare providers and reimbursement policies, the rising prevalence of lifestyle-related diseases, and the heightened focus on improving patient compliance and health outcomes.

The smart wearing glucose patch market size is expected to see rapid growth in the next few years. It will grow to $4.31 billion in 2029 at a compound annual growth rate (CAGR) of 18.1%. The growth during the forecast period can be attributed to the rise in collaborations between technology and healthcare companies, the growing consumer interest in fitness and wellness tracking, the increasing use of smartphones and apps for health monitoring, the rising preference for painless and needle-free glucose monitoring, and the growing emphasis on data-driven health insights and analytics. Key trends expected during the forecast period include improvements in sensor accuracy and data analytics, advancements in non-invasive glucose sensing techniques, the integration of multi-parameter health monitoring features, the incorporation of smart biosensors for enhanced glucose detection, and innovations in combining glucose monitoring with insulin delivery systems.

The growing prevalence of diabetes is expected to drive the growth of the smart wearable glucose patch market during the forecast period. Diabetes is a chronic metabolic condition characterized by elevated blood glucose levels resulting from the body’s inability to produce or effectively use insulin, which can lead to serious health complications if not properly managed. The increasing incidence of diabetes is primarily due to unhealthy lifestyles, as poor dietary habits and lack of physical activity contribute to obesity and insulin resistance, significantly raising the risk of diabetes. The smart wearable glucose patch supports effective diabetes management by providing continuous, real-time glucose monitoring that helps maintain stable blood sugar levels, reduces the need for invasive testing, and enables individuals to make timely lifestyle or medication adjustments for improved health outcomes. For example, in June 2024, the National Health Service (NHS), a government department in the United Kingdom, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner to 3,615,330. This marked a significant increase compared to 3,065,825 in 2022, reflecting a rise of nearly 20 percent. Therefore, the growing prevalence of diabetes is fueling the expansion of the smart wearable glucose patch market.

Major companies in the smart wearable glucose patch market are emphasizing the development of over-the-counter continuous glucose monitoring sensors to increase accessibility, improve diabetes management, and encourage proactive health tracking. Over-the-counter continuous glucose monitoring sensors are wearable devices that track glucose levels in real time without requiring a prescription, assisting individuals with type 2 diabetes or prediabetes in understanding how diet, physical activity, and lifestyle choices affect their glucose levels and enabling informed health decisions. For instance, in September 2024, Dexcom Inc., a diabetes technology company based in the United States, introduced Stelo, its first over-the-counter continuous glucose monitoring biosensor, following FDA approval earlier that year. The compact and discreet patch, worn on the upper arm, continuously measures glucose levels and transmits real-time data to a smartphone, eliminating the need for fingersticks or prescriptions. Designed for individuals with type 2 diabetes who are not using insulin and those with prediabetes, Stelo allows users to observe how diet, exercise, stress, and sleep influence their glucose levels. With a 15-day wear period, waterproof design, and an intuitive app offering daily insights and trends, Stelo enhances metabolic awareness. Flexible pay-as-you-go and subscription plans available through Dexcom’s website make advanced glucose monitoring more accessible and cost-effective.

In June 2025, PharmaSens AG, a Switzerland-based medical equipment manufacturing company, partnered with Shenzhen Sibionics Co. Ltd. to create a single patch integrating insulin delivery and glucose monitoring. Through this collaboration, PharmaSens and SiBionics aim to develop an integrated wearable device that unites insulin delivery and continuous glucose monitoring to simplify diabetes management, improve user convenience by minimizing the number of required devices and steps, and support long-term affordability and sustainability through a semi-reusable design. Shenzhen Sibionics Co. Ltd. is a China-based medical technology company that specializes in smart wearable glucose patches.

Major players in the smart wearable glucose patch market are F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Public Limited Company, Dexcom Inc., Biolinq Inc., Ascensia Diabetes Care Holdings AG, AgaMatrix Inc., Senseonics Holdings Inc., Nemaura Medical Inc., Suzhou Novosense Microelectronics Co. Ltd., RSP Systems A/S, Nutromics Ltd., Cnoga Medical Ltd., GraphWear Technologies Inc., Stelo Technology Private Limited, Afon Technology Ltd., LifePlus Inc., PKvitality S.A.S., Movano Inc., and Transdermal Diagnostics Ltd.

North America was the largest region in the smart wearable glucose patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in smart wearable glucose patch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The smart wearable glucose patch market research report is one of a series of new reports that provides smart wearable glucose patch market statistics, including smart wearable glucose patch industry global market size, regional shares, competitors with the smart wearable glucose patch market share, smart wearable glucose patch market segments, market trends, and opportunities, and any further data you may need to thrive in the smart wearable glucose patch industry. This smart wearable glucose patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A smart wearable glucose patch is a flexible biosensing device designed to continuously monitor glucose levels through the skin without requiring finger pricks. It utilizes advanced sensors to detect glucose concentrations in interstitial fluids and wirelessly transmits the data to connected devices for real-time monitoring. This technology offers convenient, noninvasive glucose management with enhanced accuracy and comfort, supporting better health tracking and more informed decision-making for maintaining optimal glucose control.

The primary product types of smart wearable glucose patches include continuous glucose monitoring patches, non-invasive glucose patches, disposable glucose patches, and reusable glucose patches. A continuous glucose monitoring patch is a wearable sensor that continuously measures glucose levels in real time, delivering actionable insights for effective diabetes management. These patches are distributed through various channels such as online retail, pharmacies, direct sales, and other distribution methods. They are used in several applications, including diabetes management, sports and fitness, remote patient monitoring, and other uses, and are utilized by multiple end-users such as hospitals and clinics, homecare settings, sports and fitness centers, and others.

The countries covered in the smart wearable glucose patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart wearable glucose patch market consists of sales of wearable glucose patches, adhesive sensor patches, microneedle biosensors, and transmitter modules. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.